Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 17.21% vs -18.63% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -1,637.50% vs 94.70% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -44.44% vs 646.34% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 27.18% vs 6.19% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Hubei Goto Biopharm Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 17.21% vs -18.63% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 46.27% vs -24.90% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -1,637.50% vs 94.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -41.84% vs -175.38% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -44.44% vs 646.34% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1,044.44% vs -109.09% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 27.18% vs 6.19% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 162.00% vs 51.52% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






